371 related articles for article (PubMed ID: 2487543)
41. Antiplatelet therapy in the prevention of ischaemic stroke.
Verry M; Panak E; Cazenave JP
Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):213-28. PubMed ID: 7971242
[TBL] [Abstract][Full Text] [Related]
42. Platelets and platelet inhibitors in acute myocardial infarction.
Kamat SG; Kleiman NS
Cardiol Clin; 1995 Aug; 13(3):435-47. PubMed ID: 7585778
[TBL] [Abstract][Full Text] [Related]
43. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM
Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638
[TBL] [Abstract][Full Text] [Related]
44. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS
Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
N Engl J Med; 1998 May; 338(21):1488-97. PubMed ID: 9599103
[TBL] [Abstract][Full Text] [Related]
46. Platelet aggregation and atherosclerosis.
Valladares BK; Lemberg L
Heart Lung; 1986 Mar; 15(2):211-4. PubMed ID: 3633253
[TBL] [Abstract][Full Text] [Related]
47. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2007 Jul; (3):CD001820. PubMed ID: 17636684
[TBL] [Abstract][Full Text] [Related]
48. Antiaggregating therapy in acute myocardial infarction.
Cimminiello C; Uberti T; Fiorista F; Marzegalli M
Eur Heart J; 1991 Dec; 12 Suppl G():30-2. PubMed ID: 1806377
[TBL] [Abstract][Full Text] [Related]
49. Antiplatelet effect of aspirin in patients with coronary artery disease.
Grove EL
Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
[TBL] [Abstract][Full Text] [Related]
50. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Tran H; Anand SS
JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
[TBL] [Abstract][Full Text] [Related]
51. Role of blood platelets in coronary artery disease.
Haft JI
Am J Cardiol; 1979 Jun; 43(6):1197-206. PubMed ID: 35967
[TBL] [Abstract][Full Text] [Related]
52. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
[TBL] [Abstract][Full Text] [Related]
53. [Antithrombotic therapy after cerebral ischemia].
Schellinger PD; Orberk E; Hacke W
Fortschr Neurol Psychiatr; 1997 Sep; 65(9):425-34. PubMed ID: 9417427
[TBL] [Abstract][Full Text] [Related]
54. Antiplatelet therapy in acute coronary syndrome and atrial fibrillation: aspirin.
Tanguay JF
Adv Cardiol; 2012; 47():20-30. PubMed ID: 22906900
[TBL] [Abstract][Full Text] [Related]
55. [Anti-aggregants in 1990].
Verstraete M
Rev Med Interne; 1990; 11(3):209-15. PubMed ID: 2096418
[TBL] [Abstract][Full Text] [Related]
56. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
Gurbel PA
Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
[TBL] [Abstract][Full Text] [Related]
57. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
Second Chinese Cardiac Study (CCS-2) Collaborative Group
J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
[TBL] [Abstract][Full Text] [Related]
58. Aspirin in the prophylaxis of coronary artery disease.
Mehta P
Curr Opin Cardiol; 2002 Sep; 17(5):552-8. PubMed ID: 12357134
[TBL] [Abstract][Full Text] [Related]
59. Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study.
Jneid H; Bhatt DL; Corti R; Badimon JJ; Fuster V; Francis GS
Arch Intern Med; 2003 May; 163(10):1145-53. PubMed ID: 12767950
[TBL] [Abstract][Full Text] [Related]
60. Antiplatelet therapy in coronary artery disease: review and update of efficacy studies.
Tisdale JE
Am J Health Syst Pharm; 1998 Oct; 55(19 Suppl 1):S8-16. PubMed ID: 9784797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]